Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study
Conclusion: In this open, prospective study, RTX appeared to be very effective and safe in the treatment of the most severe cases of MC.Am J Nephrol 2016;43:251-260
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Glomerulonephritis | Hepatitis | Hepatitis C | Neurology | Peripheral Neuropathy | Proteinuria | Rituxan | Skin | Study | Urology & Nephrology